We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

166 hedge funds and large institutions have $851M invested in Meridian Bioscience Inc in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 56 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 56

2% less funds holding

Funds holding: 170 → 166 (-4)

13% less call options, than puts

Call options by funds: $435K | Put options by funds: $498K

17% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 23

20% less capital invested

Capital invested by funds: $1.06B → $851M (-$207M)

Holders
166
Holders Change
-4
Holders Change %
-2.35%
% of All Funds
4.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
61
Reduced
56
Closed
23
Calls
$435K
Puts
$498K
Net Calls
-$63K
Net Calls Change
-$235K

Top Buyers

Rank Fund Capital Flow
1
PIM
Perkins Investment Management
Illinois
+$19M
2
CIC
Crawford Investment Counsel
Georgia
+$7.11M
3
Renaissance Technologies
Renaissance Technologies
New York
+$6.73M
4
CAI
Capital Advisors Inc
Oklahoma
+$4.43M
5
Deutsche Bank
Deutsche Bank
Germany
+$3.58M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$21.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$13.6M
3
CFC
Cincinnati Financial Corp
Ohio
-$12.6M
4
CCA
Conestoga Capital Advisors
Pennsylvania
-$5.98M
5
CAM
Capstone Asset Management
Texas
-$3.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
DAS
176
Dynamic Advisor Solutions
Arizona
– -$292K -11,015 Closed
NPIT
177
National Penn Investors Trust
Pennsylvania
– -$276K -10,420 Closed
Nomura Holdings
178
Nomura Holdings
Japan
– -$226K -8,558 Closed
Cambridge Investment Research Advisors
179
Cambridge Investment Research Advisors
Iowa
– -$218K -8,234 Closed
PP
180
Paloma Partners
Connecticut
– -$207K -7,785 Closed
ICM
181
IMS Capital Management
Oregon
– -$204K -7,676 Closed
DADC
182
D.A. Davidson & Co
Montana
– -$24K -933 Closed
SOADOR
183
State of Alaska Department of Revenue
Alaska
– -$23K -900 Closed
BJ
184
BlackRock Japan
Japan
– -$23K -866 Closed
KBC Group
185
KBC Group
Belgium
– -$21K -792 Closed
BNP Paribas Financial Markets
186
BNP Paribas Financial Markets
France
– -$14.2K -537 Closed
BC
187
Blackhill Capital
New Jersey
– -$12K -450 Closed
HRIA
188
Haberer Registered Investment Advisor
Ohio
– -$3K -100 Closed
PO
189
Private Ocean
California
– -$2K -89 Closed
4 5 6 7
8

VIVO Hedge Fund Activity: Q1 2014 in Review

166 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2014, worth a combined $851M — down 20% from $1.06B a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of VIVO and 19 opened new positions — a net loss of 4 holders — while 56 trimmed existing stakes and 61 added.

The largest buyer was Perkins Investment Management, opening a new position worth an estimated $19M. The largest seller was Invesco, cutting an estimated $21.5M.

  • 166 institutional investors held Meridian Bioscience Inc (VIVO) as of Q1 2014, down from 170 in Q4 2013.
  • Funds reported $851M of Meridian Bioscience Inc stock for Q1 2014, down 20% quarter-over-quarter.
  • 19 funds opened new Meridian Bioscience Inc positions in Q1 2014 and 23 closed out, a net change of -4 holders.
  • The largest Meridian Bioscience Inc buyer in Q1 2014 was Perkins Investment Management, an estimated $19M added.
  • The largest Meridian Bioscience Inc seller in Q1 2014 was Invesco, an estimated $21.5M sold.

Based on aggregated 13F filings for Q1 2014.